Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6252 USD | +9.88% |
|
-7.21% | +9.68% |
12/06 | XOMA Receives $8.1 Million Milestone Related to Sale of Priority Review Voucher | MT |
30/05 | Day One Biopharmaceuticals Sells Priority Review Voucher for $108 Million | MT |
- Stock Market
- Equities
- VIRX Stock
- News Viracta Therapeutics, Inc.
- MarketScreener Editorial Features